Jubilant Organosys acquired Hollister-Stier
On Apr. 25, 2007, Jubilant Organosys, Ltd. announced it had acquired Spokane-based Hollister-Stier for $122.5 million. The plant…
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
National Cancer Institute scientists identified novel protein that ties disruption of critical cellular pathway to Birt-Hogg-Dub syndrome
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Fred Hutchinson Cancer Research Center Joined Livestrong™ Survivorship Center of Excellence Network
On Mar. 20, 2006, the Fred Hutchinson Cancer Research Center announced that it had joined the Lance Armstrong…
Acorda Therapeutics announced its its initial public offering
On Feb. 10, 2006, Acorda Therapeutics announced an initial public offering of 5,500,000 shares of common stock at…
Agriculture | Disease | Life Science News | USDA | Vaccine
USDA granted Dow AgroSciences the first regulatory approval for a plant-made vaccine
In 2006, the U.S. Department of Agriculture (USDA) granted Dow AgroSciences the first regulatory approval for a plant-made…
The prevalence of U.S. adult smoking declined to 20.8 percent in 2006
In 2006, an estimated 20.8% (45.3 million) of U.S. adults were current cigarette smokers; of these, 80.1% (36.3…
The Science Foundation Arizona was founded
In 2006, the Science Foundation Arizona (SFAz), a 501(C)(3) non profit, was initiated by the three statewide CEO…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics
Robert C. Byrd Biotechnology Science Center opened
In 2006, Robert C. Byrd Biotechnology Science Center officially opened. The center was constructed with a grant of…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center opened a new center at Barnes-Jewish St Peters Hospital
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
Biotechnology | Disease | NIH | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
Autism Speaks was founded in New York City
On Feb. 11, 2005, Autism Speaks was founded in New York City by Bob and Suzanne Wright, grandparents…
World Cancer Day was established by The World Health Organization
On Feb. 4, 2005, World Cancer Day was established by The World Health Organization. Cancer is a leading…
Smallpox appeared in the first agricultural settlements in northeastern Africa
On Jan. 8, 2005, researchers from Baylor University Medical Center reported that although the origin of smallpox is…
Genome Alberta was established
In 2005, Genome Alberta, was established in partnership with Genome Canada Industry Canada and the Province of Alberta,…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Schnitzer Investment Corporation donated nearly 20 acres of riverfront property in South Waterfront to OHSU
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Ophthalmogy | Therapeutics
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Ophthalmogy
OHSU researcher uncovered macular degeneration gene
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Scripps Research Institute announced the establishment of a major science center in Palm Beach County, Florida
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
The National Center for Research Resources awarded a $67 million grant to UGA for a Parkinson’s disease study
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics
Results of the Prostate Cancer Prevention Trial were announced
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
Genentech drug Xolair (omalizumab) was approved
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
The Curious Incident of the Dog in the Night-Time was published
On May 1, 2003, Mark Haddon’s The Curious Incident of the Dog in the Night-Time was published, allowing…